#PAGE_PARAMS# #ADS_HEAD_SCRIPTS# #MICRODATA#

The Number of X Chromosomes Causes Sex Differences in Adiposity in Mice


Sexual dimorphism in body weight, fat distribution, and metabolic disease has been attributed largely to differential effects of male and female gonadal hormones. Here, we report that the number of X chromosomes within cells also contributes to these sex differences. We employed a unique mouse model, known as the “four core genotypes,” to distinguish between effects of gonadal sex (testes or ovaries) and sex chromosomes (XX or XY). With this model, we produced gonadal male and female mice carrying XX or XY sex chromosome complements. Mice were gonadectomized to remove the acute effects of gonadal hormones and to uncover effects of sex chromosome complement on obesity. Mice with XX sex chromosomes (relative to XY), regardless of their type of gonad, had up to 2-fold increased adiposity and greater food intake during daylight hours, when mice are normally inactive. Mice with two X chromosomes also had accelerated weight gain on a high fat diet and developed fatty liver and elevated lipid and insulin levels. Further genetic studies with mice carrying XO and XXY chromosome complements revealed that the differences between XX and XY mice are attributable to dosage of the X chromosome, rather than effects of the Y chromosome. A subset of genes that escape X chromosome inactivation exhibited higher expression levels in adipose tissue and liver of XX compared to XY mice, and may contribute to the sex differences in obesity. Overall, our study is the first to identify sex chromosome complement, a factor distinguishing all male and female cells, as a cause of sex differences in obesity and metabolism.


Vyšlo v časopise: The Number of X Chromosomes Causes Sex Differences in Adiposity in Mice. PLoS Genet 8(5): e32767. doi:10.1371/journal.pgen.1002709
Kategorie: Research Article
prolekare.web.journal.doi_sk: https://doi.org/10.1371/journal.pgen.1002709

Souhrn

Sexual dimorphism in body weight, fat distribution, and metabolic disease has been attributed largely to differential effects of male and female gonadal hormones. Here, we report that the number of X chromosomes within cells also contributes to these sex differences. We employed a unique mouse model, known as the “four core genotypes,” to distinguish between effects of gonadal sex (testes or ovaries) and sex chromosomes (XX or XY). With this model, we produced gonadal male and female mice carrying XX or XY sex chromosome complements. Mice were gonadectomized to remove the acute effects of gonadal hormones and to uncover effects of sex chromosome complement on obesity. Mice with XX sex chromosomes (relative to XY), regardless of their type of gonad, had up to 2-fold increased adiposity and greater food intake during daylight hours, when mice are normally inactive. Mice with two X chromosomes also had accelerated weight gain on a high fat diet and developed fatty liver and elevated lipid and insulin levels. Further genetic studies with mice carrying XO and XXY chromosome complements revealed that the differences between XX and XY mice are attributable to dosage of the X chromosome, rather than effects of the Y chromosome. A subset of genes that escape X chromosome inactivation exhibited higher expression levels in adipose tissue and liver of XX compared to XY mice, and may contribute to the sex differences in obesity. Overall, our study is the first to identify sex chromosome complement, a factor distinguishing all male and female cells, as a cause of sex differences in obesity and metabolism.


Zdroje

1. BlakemoreAIFroguelP 2010 Investigation of Mendelian forms of obesity holds out the prospect of personalized medicine. Ann N Y Acad Sci 1214 180 189

2. DonkorJReueK 2010 Mouse models of lipodystrophy. LeffTGrannemanJ Adipose Tissue in Health and Disease Weinheim Wiley-VCH 403 422

3. O'RahillyS 2009 Human genetics illuminates the paths to metabolic disease. Nature 462 307 314

4. LusisAJAttieADReueK 2008 Metabolic syndrome: from epidemiology to systems biology. Nat Rev Genet 9 819 830

5. KotaniKTokunagaKFujiokaSKobatakeTKenoY 1994 Sexual dimorphism of age-related changes in whole-body fat distribution in the obese. Int J Obes Relat Metab Disord 18 207 202

6. LovejoyJCChampagneCMde JongeLXieHSmithSR 2008 Increased visceral fat and decreased energy expenditure during the menopausal transition. Int J Obes (Lond) 32 949 958

7. MacotelaYBoucherJTranTTKahnCR 2009 Sex and depot differences in adipocyte insulin sensitivity and glucose metabolism. Diabetes 58 803 812

8. PowerMLSchulkinJ 2008 Sex differences in fat storage, fat metabolism, and the health risks from obesity: possible evolutionary origins. Br J Nutr 99 931 940

9. WajchenbergBL 2000 Subcutaneous and visceral adipose tissue: their relation to the metabolic syndrome. Endocr Rev 21 697 738

10. NielsenSGuoZJohnsonCMHensrudDDJensenMD 2004 Splanchnic lipolysis in human obesity. J Clin Invest 113 1582 1588

11. CnopMHavelPJUtzschneiderKMCarrDBSinhaMK 2003 Relationship of adiponectin to body fat distribution, insulin sensitivity and plasma lipoproteins: evidence for independent roles of age and sex. Diabetologia 46 459 469

12. CombsTPBergAHRajalaMWKlebanovSIyengarP 2003 Sexual differentiation, pregnancy, calorie restriction, and aging affect the adipocyte-specific secretory protein adiponectin. Diabetes 52 268 276

13. HavelPJKasim-KarakasSDubucGRMuellerWPhinneySD 1996 Gender differences in plasma leptin concentrations. Nat Med 2 949 950

14. ShiHStraderADWoodsSCSeeleyRJ 2007 Sexually dimorphic responses to fat loss after caloric restriction or surgical lipectomy. Am J Physiol Endocrinol Metab 293 E316 E326

15. BrownLMGentLDavisKCleggDJ 2010 Metabolic impact of sex hormones on obesity. Brain Res 1350 77 85

16. PallottiniVBulzomiPGalluzzoPMartiniCMarinoM 2008 Estrogen regulation of adipose tissue functions: involvement of estrogen receptor isoforms. Infect Disord Drug Targets 8 52 60

17. GarauletMPerez-LlamasFBarazaJCGarcia-PrietoMDFardyPS 2002 Body fat distribution in pre-and post-menopausal women: metabolic and anthropometric variables. J Nutr Health Aging 6 123 126

18. HeinePATaylorJAIwamotoGALubahnDBCookePS 2000 Increased adipose tissue in male and female estrogen receptor-alpha knockout mice. Proc Natl Acad Sci U S A 97 12729 12734

19. BlouinKBoivinATchernofA 2008 Androgens and body fat distribution. J Steroid Biochem Mol Biol 108 272 280

20. DunaifA 1997 Insulin resistance and the polycystic ovary syndrome: mechanism and implications for pathogenesis. Endocr Rev 18 774 800

21. FanWYanaseTNomuraMOkabeTGotoK 2005 Androgen receptor null male mice develop late-onset obesity caused by decreased energy expenditure and lipolytic activity but show normal insulin sensitivity with high adiponectin secretion. Diabetes 54 1000 1008

22. SatoTMatsumotoTYamadaTWatanabeTKawanoH 2003 Late onset of obesity in male androgen receptor-deficient (AR KO) mice. Biochem Biophys Res Commun 300 167 171

23. BukowskiRSmithGCMaloneFDBallRHNybergDA 2007 Human sexual size dimorphism in early pregnancy. Am J Epidemiol 165 1216 1218

24. BurgoynePSThornhillARBoudreanSKDarlingSMBishopCE 1995 The genetic basis of XX-XY differences present before gonadal sex differentiation in the mouse. Philos Trans R Soc Lond B Biol Sci 350 253 260 discussion 260-251

25. ArnoldAP 2009 Mouse models for evaluating sex chromosome effects that cause sex differences in non-gonadal tissues. J Neuroendocrinol 21 377 386

26. ArnoldAPBurgoynePS 2004 Are XX and XY brain cells intrinsically different? Trends Endocrinol Metab 15 6 11

27. ArnoldAPChenX 2009 What does the “four core genotypes” mouse model tell us about sex differences in the brain and other tissues? Front Neuroendocrinol 30 1 9

28. ArnoldAP 2011 The end of gonad-centric sex determination in mammals. Trends Genet in press

29. GoodfellowPNLovell-BadgeR 1993 SRY and sex determination in mammals. Annu Rev Genet 27 71 92

30. ItohYMelamedEYangXKampfKWangS 2007 Dosage compensation is less effective in birds than in mammals. J Biol 6 2

31. BerletchJBYangFDistecheCM 2010 Escape from X inactivation in mice and humans. Genome Biol 11 213

32. BrownCJGreallyJM 2003 A stain upon the silence: genes escaping X inactivation. Trends Genet 19 432 438

33. ProtheroKEStahlJMCarrelL 2009 Dosage compensation and gene expression on the mammalian X chromosome: one plus one does not always equal two. Chromosome Res 17 637 648

34. YangFBabakTShendureJDistecheCM 2010 Global survey of escape from X inactivation by RNA-sequencing in mouse. Genome Res 20 614 622

35. LopesAMBurgoynePSOjarikreABauerJSargentCA 2010 Transcriptional changes in response to X chromosome dosage in the mouse: implications for X inactivation and the molecular basis of Turner Syndrome. BMC Genomics 11 82

36. De VriesGJRissmanEFSimerlyRBYangLYScordalakesEM 2002 A model system for study of sex chromosome effects on sexually dimorphic neural and behavioral traits. J Neurosci 22 9005 9014

37. EllacottKLMortonGJWoodsSCTsoPSchwartzMW 2010 Assessment of feeding behavior in laboratory mice. Cell Metab 12 10 17

38. ButlerAAKozakLP 2010 A recurring problem with the analysis of energy expenditure in genetic models expressing lean and obese phenotypes. Diabetes 59 323 329

39. KaiyalaKJSchwartzMW 2011 Toward a more complete (and less controversial) understanding of energy expenditure and its role in obesity pathogenesis. Diabetes 60 17 23

40. SurwitRSKuhnCMCochraneCMcCubbinJAFeinglosMN 1988 Diet-induced type II diabetes in C57BL/6J mice. Diabetes 37 1163 1167

41. ChenXWatkinsRDelotERelieneRSchiestlRH 2008 Sex difference in neural tube defects in p53-null mice is caused by differences in the complement of X not Y genes. Dev Neurobiol 68 265 273

42. XuJBurgoynePSArnoldAP 2002 Sex differences in sex chromosome gene expression in mouse brain. Hum Mol Genet 11 1409 1419

43. XuJTayaSKaibuchiKArnoldAP 2005 Sexually dimorphic expression of Usp9x is related to sex chromosome complement in adult mouse brain. Eur J Neurosci 21 3017 3022

44. GroveKLFriedSKGreenbergASXiaoXQCleggDJ 2010 A microarray analysis of sexual dimorphism of adipose tissues in high-fat-diet-induced obese mice. Int J Obes (Lond) 34 989 1000

45. GambaccianiMCiaponiMCappagliBPiaggesiLDe SimoneL 1997 Body weight, body fat distribution, and hormonal replacement therapy in early postmenopausal women. J Clin Endocrinol Metab 82 414 417

46. HaarboJMarslewUGotfredsenAChristiansenC 1991 Postmenopausal hormone replacement therapy prevents central distribution of body fat after menopause. Metabolism 40 1323 1326

47. LeeCGCarrMCMurdochSJMitchellEWoodsNF 2009 Adipokines, inflammation, and visceral adiposity across the menopausal transition: a prospective study. J Clin Endocrinol Metab 94 1104 1110

48. Van PeltREJankowskiCMGozanskyWSSchwartzRSKohrtWM 2005 Lower-body adiposity and metabolic protection in postmenopausal women. J Clin Endocrinol Metab 90 4573 4578

49. WoodhouseLJGuptaNBhasinMSinghABRossR 2004 Dose-dependent effects of testosterone on regional adipose tissue distribution in healthy young men. J Clin Endocrinol Metab 89 718 726

50. ArbleDMBassJLaposkyADVitaternaMHTurekFW 2009 Circadian timing of food intake contributes to weight gain. Obesity 17 2100 2102

51. BassJTakahashiJS 2010 Circadian integration of metabolism and energetics. Science 330 1349 1354

52. HuangWRamseyKMMarchevaBBassJ 2011 Circadian rhythms, sleep, and metabolism. J Clin Invest 121 2133 2141

53. RomanskiSANelsonRMJensenMD 2000 Meal fatty acid uptake in adipose tissue: gender effects in nonobese humans. Am J Physiol Endocrinol Metab 279 E455 E462

54. CohenJCHortonJDHobbsHH 2011 Human fatty liver disease: old questions and new insights. Science 332 1519 1523

55. KopecKLBurnsD 2011 Nonalcoholic fatty liver disease: a review of the spectrum of disease, diagnosis, and therapy. Nutr Clin Pract 26 565 576

56. CarrelLWillardHF 2005 X-inactivation profile reveals extensive variability in X-linked gene expression in females. Nature 434 400 404

57. JohnstonCMLovellFLLeongamornlertDAStrangerBEDermitzakisET 2008 Large-scale population study of human cell lines indicates that dosage compensation is virtually complete. PLoS Genet 4 e9 doi:10.1371/journal.pgen.0040009

58. BakalovVKChengCZhouJBondyCA 2009 X-chromosome gene dosage and the risk of diabetes in Turner syndrome. J Clin Endocrinol Metab 94 3289 3296

59. BardsleyMZFalknerBKowalKRossJL 2011 Insulin resistance and metabolic syndrome in prepubertal boys with Klinefelter syndrome. Acta Paediatr 100 866 870

60. BojesenAKristensenKBirkebaekNHFedderJMosekildeL 2006 The metabolic syndrome is frequent in Klinefelter's syndrome and is associated with abdominal obesity and hypogonadism. Diabetes Care 29 1591 1598

61. VanPLBakalovVKBondyCA 2006 Monosomy for the X-chromosome is associated with an atherogenic lipid profile. J Clin Endocrinol Metab 91 2867 2870

62. TaicherGZTinsleyFCReidermanAHeimanML 2003 Quantitative magnetic resonance (QMR) method for bone and whole-body composition analysis. Anal Bioanal Chem 377 990 1002

63. VergnesLBeigneuxAPDavisRWatkinsSMYoungSG 2006 Agpat6 deficiency causes subdermal lipodystrophy and resistance to obesity. J Lipid Res 47 745 754

Štítky
Genetika Reprodukčná medicína

Článok vyšiel v časopise

PLOS Genetics


2012 Číslo 5
Najčítanejšie tento týždeň
Najčítanejšie v tomto čísle
Kurzy

Zvýšte si kvalifikáciu online z pohodlia domova

Získaná hemofilie - Povědomí o nemoci a její diagnostika
nový kurz

Eozinofilní granulomatóza s polyangiitidou
Autori: doc. MUDr. Martina Doubková, Ph.D.

Všetky kurzy
Prihlásenie
Zabudnuté heslo

Zadajte e-mailovú adresu, s ktorou ste vytvárali účet. Budú Vám na ňu zasielané informácie k nastaveniu nového hesla.

Prihlásenie

Nemáte účet?  Registrujte sa

#ADS_BOTTOM_SCRIPTS#